Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
クイックコネクト

ニュース

Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards

2021

Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards

COVID-19: Prime Minister of India's Meets Pharma leaders

2021

COVID-19: Prime Minister of India's Meets Pharma leaders

The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards

2021

The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards

The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021

2021

The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021

Sugammadex sodium API – CADIFA approval

2021

Sugammadex Sodium API – CADIFA Approval by ANVISA

Deepak Sapra speaks about DRDO’s anti-covid drug 2DG

2021

Deepak Sapra speaks about DRDO’s anti-covid drug 2DG

Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today

2021

Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today

Best Supply Chain Team of the Year - Pharma- 2021

2021

Best Supply Chain Team of the Year - Pharma- 2021

Dr. Reddy’s Laboratories’ Anil Patni presented on HPAPIs at Manufacturing Chemist Live Virtual

2020

Dr. Reddy’s Laboratories’ Anil Patni presented on HPAPIs at Manufacturing Chemist Live Virtual

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020

2020

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020

Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’

2020

Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’

Dr. Reddy’s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets

2020

Dr. Reddy’s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets

CPhI Festival of Pharma Panel discussion: Innovation Across Borders: How Pharma and innovators are fighting Back Against COVID-19 and ways forward.

2020

CPhI Festival of Pharma Panel discussion: Innovation Across Borders: How Pharma and innovators are fighting Back Against COVID-19 and ways forward.

CPhI Festival of Pharma Roundtable: Tackling Nitrosamine Contamination

2020

CPhI Festival of Pharma Roundtable: Tackling Nitrosamine Contamination

Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19

2020

Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19

Dr. Reddy’s is featured in an article of Global Pharma Insights on “Nitrosamine contamination: pharma’s re-evaluation of its supply chain”

2020

Dr. Reddy’s is featured in an article of Global Pharma Insights on “Nitrosamine contamination: pharma’s re-evaluation of its supply chain”

Dr. Reddy’s statement on the COVID-19 pandemic

2020

Dr. Reddy’s statement on the COVID-19 pandemic

Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate

2020

Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate

US DMF for Apalutamide - Now available

2020

US DMF for Apalutamide - Now available

Dr. Reddy's Sustainability Report 2018-19

2020

Dr. Reddy's Sustainability Report 2018-19

Dr. Reddy's API Team moves into its new office in China

2019

Dr. Reddy's API Team moves into its new office in China

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2019

2019

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2019

X
Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit

The website encountered an unexpected error. Please try again later.